Venus Concept Inc
VERO1.140USD
-0.040-3.39%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
2.12MMarket Cap
LossP/E TTM
More Details of Venus Concept Inc Company
Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
Venus Concept Inc Info
Ticker SymbolVERO
Company nameVenus Concept Inc
IPO dateOct 12, 2017
CEODe Silva (Rajiv D)
Number of employees292
Security typeOrdinary Share
Fiscal year-endOct 12
Address235 Yorkland Blvd Suite 900
CityTORONTO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryCanada
Postal codeM2J 4Y8
Phone18778488430
Websitehttps://www.venusconcept.com/en-uk/
Ticker SymbolVERO
IPO dateOct 12, 2017
CEODe Silva (Rajiv D)
Company Executives of Venus Concept Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Stanley Tyler Hollmig, M.D.
Dr. Stanley Tyler Hollmig, M.D.
Independent Director
Independent Director
1.76K
--
Mr. Kirk Gunhus
Mr. Kirk Gunhus
Chief Revenue Officer
Chief Revenue Officer
1.64K
+1637.00%
Mr. Ross J. Portaro
Mr. Ross J. Portaro
Executive Vice President - Commercial Strategy and Head - Venus Hair
Executive Vice President - Commercial Strategy and Head - Venus Hair
812.00
--
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
Independent Director
Independent Director
753.00
+1.00%
Ms. Anna Georgiadis
Ms. Anna Georgiadis
Chief Human Resources Officer
Chief Human Resources Officer
157.00
+1.00%
Mr. Michael Mandarello
Mr. Michael Mandarello
Chief Legal Officer, Head of Strategy & Operations
Chief Legal Officer, Head of Strategy & Operations
136.00
--
Mr. Domenic Della Penna, CPA
Mr. Domenic Della Penna, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Melissa Kang, CPA
Ms. Melissa Kang, CPA
Chief Product Officer
Chief Product Officer
--
--
Ms. Louise M. Lacchin
Ms. Louise M. Lacchin
Independent Director
Independent Director
--
--
Dr. Anthony J. (Tony) Natale, M.D.
Dr. Anthony J. (Tony) Natale, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Stanley Tyler Hollmig, M.D.
Dr. Stanley Tyler Hollmig, M.D.
Independent Director
Independent Director
1.76K
--
Mr. Kirk Gunhus
Mr. Kirk Gunhus
Chief Revenue Officer
Chief Revenue Officer
1.64K
+1637.00%
Mr. Ross J. Portaro
Mr. Ross J. Portaro
Executive Vice President - Commercial Strategy and Head - Venus Hair
Executive Vice President - Commercial Strategy and Head - Venus Hair
812.00
--
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
Independent Director
Independent Director
753.00
+1.00%
Ms. Anna Georgiadis
Ms. Anna Georgiadis
Chief Human Resources Officer
Chief Human Resources Officer
157.00
+1.00%
Mr. Michael Mandarello
Mr. Michael Mandarello
Chief Legal Officer, Head of Strategy & Operations
Chief Legal Officer, Head of Strategy & Operations
136.00
--
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Products—Systems
7.86M
57.06%
Subscription—Systems
2.94M
21.31%
Products—Other
2.33M
16.93%
Services
647.00K
4.70%
By RegionUSD
Name
Revenue
Proportion
United States
7.49M
54.36%
International
6.29M
45.64%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Products—Systems
7.86M
57.06%
Subscription—Systems
2.94M
21.31%
Products—Other
2.33M
16.93%
Services
647.00K
4.70%
Shareholding Stats
Updated: Wed, Dec 3
Updated: Wed, Dec 3
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Orca Capital GmbH
5.47%
EW Healthcare Partners
5.33%
HealthQuest Capital Management, L.P
2.22%
DRW Securities, LLC
1.60%
Madryn Asset Management, LP
0.55%
Other
84.84%
Shareholders
Shareholders
Proportion
Orca Capital GmbH
5.47%
EW Healthcare Partners
5.33%
HealthQuest Capital Management, L.P
2.22%
DRW Securities, LLC
1.60%
Madryn Asset Management, LP
0.55%
Other
84.84%
Shareholder Types
Shareholders
Proportion
Venture Capital
7.54%
Investment Advisor
7.48%
Individual Investor
0.82%
Private Equity
0.55%
Investment Advisor/Hedge Fund
0.33%
Hedge Fund
0.10%
Research Firm
0.04%
Other
83.14%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
34
298.27K
16.04%
+102.48K
2025Q3
33
256.25K
13.78%
+62.51K
2025Q2
48
303.44K
16.32%
+73.80K
2025Q1
57
222.57K
25.52%
+13.74K
2024Q4
59
229.67K
34.82%
+28.01K
2024Q3
64
3.05M
44.61%
-537.66K
2024Q2
70
3.54M
52.45%
+304.55K
2024Q1
74
3.18M
52.95%
-445.34K
2023Q4
77
2.92M
53.20%
-420.44K
2023Q3
87
3.15M
119.91%
-295.52K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Orca Capital GmbH
101.75K
5.47%
+101.75K
--
Jun 06, 2025
EW Healthcare Partners
99.02K
5.33%
--
--
Sep 30, 2025
HealthQuest Capital Management, L.P
41.19K
2.22%
--
--
Dec 31, 2024
DRW Securities, LLC
29.66K
1.6%
+29.66K
--
Sep 30, 2025
Madryn Asset Management, LP
10.19K
0.55%
--
--
Dec 11, 2025
De Silva (Rajiv)
7.58K
0.41%
--
--
Apr 28, 2025
Geode Capital Management, L.L.C.
6.12K
0.33%
--
--
Nov 30, 2025
UBS Financial Services, Inc.
7.79K
0.42%
+7.79K
--
Sep 30, 2025
The Vanguard Group, Inc.
2.03K
0.11%
--
--
Nov 30, 2025
Tower Research Capital LLC
1.94K
0.1%
-1.98K
-50.45%
Sep 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
Date
Ex-dividend Date
Type
Ratio
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
